A new investigation has found that 72% of patent applications linked to the 10 top-selling prescription drugs in the US for 2021 were filed after receiving approval from the US Food and Drug Administration.
Patent thickets are a tactic used by drug developers to delay generics from entering the market. They can limit off-patent...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?